ConductScience.org, home

Paper36969713

Pompe Disease: a Clinical, Diagnostic, and Therapeutic Overview.

Stevens D and 2 others. Curr Treat Options Neurol, 2022. Cited by 58 papers, by iCite.

Cite this record

ConductScience Library. Pompe Disease: a Clinical, Diagnostic, and Therapeutic Overview. Papers, record 36969713. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36969713

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pompe Disease: a Clinical, Diagnostic, and Therapeutic Overview.
PubMed
Journal
Curr Treat Options Neurol
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
58
iCite
Relative citation ratio, by iCite
5.18
iCite
Revised in PubMed
2023-03-29
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stevens DDavid
2Milani-Nejad SShadi
3Mozaffar TTahseenhttps://orcid.org/0000-0002-1230-0188

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AR078340NIAMS NIH HHSUnited StatesR01AR078340PubMed and NIHNIH RePORTER
U24 NS107210NINDS NIH HHSUnited StatesU24NS107210PubMed and NIHNIH RePORTER
UL1 TR001414NCATS NIH HHSUnited StatesUL1TR001414PubMed and NIHNIH RePORTER

Download CSV of grants

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121232767Later-onset Pompe disease: early detection and early treatment initiation enabled by newborn screening.J Pediatr2011https://conductscience.org/library/papers/21232767PubMed
231796685Advancements in AAV-mediated Gene Therapy for Pompe Disease.J Neuromuscul Dis2020https://conductscience.org/library/papers/31796685PubMed
323570273Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes.Hum Gene Ther2013https://conductscience.org/library/papers/23570273PubMed
426830551Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD).J Inherit Metab Dis2016https://conductscience.org/library/papers/26830551PubMed
516702877Pompe disease diagnosis and management guideline.Genet Med2006https://conductscience.org/library/papers/16702877PubMed
631522955Antibody-Mediated Enzyme Therapeutics and Applications in Glycogen Storage Diseases.Trends Mol Med2019https://conductscience.org/library/papers/31522955PubMed
731794466Myotonic Muscular Dystrophies.Continuum (Minneap Minn)2019https://conductscience.org/library/papers/31794466PubMed
828856460Late-onset Pompe disease: a genetic-radiological correlation on cerebral vascular anomalies.J Neurol2017https://conductscience.org/library/papers/28856460PubMed
916426990Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial.Lancet Neurol2006https://conductscience.org/library/papers/16426990PubMed
1033451932Effect of long term enzyme replacement therapy in late onset Pompe disease: A single-centre experience.Neuromuscul Disord2021https://conductscience.org/library/papers/33451932PubMed
1121825984Limb girdle muscular dystrophies: update on genetic diagnosis and therapeutic approaches.Curr Opin Neurol2011https://conductscience.org/library/papers/21825984PubMed
1234400331Cell type-selective targeted delivery of a recombinant lysosomal enzyme for enzyme therapies.Mol Ther2021https://conductscience.org/library/papers/34400331PubMed
1321543987Cardiovascular abnormalities in late-onset Pompe disease and response to enzyme replacement therapy.Genet Med2011https://conductscience.org/library/papers/21543987PubMed
1432134266Discovery and Development of Small-Molecule Inhibitors of Glycogen Synthase.J Med Chem2020https://conductscience.org/library/papers/32134266PubMed
1529162675Management of Confirmed Newborn-Screened Patients With Pompe Disease Across the Disease Spectrum.Pediatrics2017https://conductscience.org/library/papers/29162675PubMed
1610078739A diagnostic protocol for adult-onset glycogen storage disease type II.Neurology1999https://conductscience.org/library/papers/10078739PubMed
1710482961Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling.Eur J Hum Genet1999https://conductscience.org/library/papers/10482961PubMed
1825296331Reproducibility and absolute quantification of muscle glycogen in patients with glycogen storage disease by 13C NMR spectroscopy at 7 Tesla.PLoS One2014https://conductscience.org/library/papers/25296331PubMed
1933073007The First Year Experience of Newborn Screening for Pompe Disease in California.Int J Neonatal Screen2020https://conductscience.org/library/papers/33073007PubMed
2022676651A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations.Orphanet J Rare Dis2012https://conductscience.org/library/papers/22676651PubMed

See all 54 referencesDownload CSV of references

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.

PMIDTitleJournalYearIn PapersSource
42871814Evaluation of Pompe Disease from a Broad and Systemic Perspective.J Clin Pract Res2026https://conductscience.org/library/papers/42871814PubMed
42633127GAA engineered to improve cellular uptake enhances correction in a preclinical hematopoietic stem cell gene therapy model of Pompe disease.Mol Ther Adv2026https://conductscience.org/library/papers/42633127PubMed
42353063Carrier Frequencies of Medically Actionable Pathogenic Variants in the Russian Population.Int J Mol Sci2026https://conductscience.org/library/papers/42353063PubMed
41653352Measuring What Matters to Patients with Pompe Disease: A Review of Clinical Outcome Assessments for Capturing Treatment Benefits of Innovative Novel Therapies.Adv Ther2026https://conductscience.org/library/papers/41653352PubMed
41622854Longitudinal characterization of Gaac.1826dupA mice reveals the cardiac, myopathic and biochemical phenotypes of Pompe disease.Dis Model Mech2026https://conductscience.org/library/papers/41622854PubMed
41586257Beginning of a new era of synthetic messenger RNA therapeutics: Comprehensive insights on mRNA drug design, development and applications.Exp Biol Med (Maywood)2025https://conductscience.org/library/papers/41586257PubMed
41536902Early initiation of enzyme replacement therapy as facilitated by newborn screening improves health outcomes among patients with infantile-onset Pompe disease.Genet Med Open2026https://conductscience.org/library/papers/41536902PubMed
41463072Hypertrophic Cardiomyopathy Phenocopies: Classification, Key Features, and Differential Diagnosis.Biomedicines2025https://conductscience.org/library/papers/41463072PubMed
41326286New therapeutic strategies for Lafora disease: Evaluation of the safety, efficacy, pharmacokinetics and metabolomic profile of intravenous VAL-1221 treatment.Neurotherapeutics2026https://conductscience.org/library/papers/41326286PubMed
41317268Current Achievements in Gene Therapy Strategies and Delivery Systems in Preclinical and Clinical Models of Heart Failure.Curr Heart Fail Rep2025https://conductscience.org/library/papers/41317268PubMed
41286962The Global Hypophosphatasia Registry: lessons learned from a decade of real-world data.Orphanet J Rare Dis2025https://conductscience.org/library/papers/41286962PubMed
41229640When the Diaphragm Fails: Visual Hallucinations Due to Isolated Respiratory Muscle Weakness as a First Manifestation of Late-Onset Pompe Disease.Eur J Case Rep Intern Med2025https://conductscience.org/library/papers/41229640PubMed
41161912The Mythology of Polymyositis.Rheum Dis Clin North Am2025https://conductscience.org/library/papers/41161912PubMed
41158907Anaesthetic Management of Advanced Late-Onset Pompe Disease: Challenges in a Major Abdominal Surgery.Cureus2025https://conductscience.org/library/papers/41158907PubMed
41148004A retrospective cohort study describing the disease burden in patients with Pompe disease treated with enzyme replacement therapy in the United States.J Neuromuscul Dis2026https://conductscience.org/library/papers/41148004PubMed
41078577Molecular characterization of a novel synonymous variant in a Mexican patient with Pompe disease.Mol Genet Metab Rep2025https://conductscience.org/library/papers/41078577PubMed
41049133Transcriptional profiling reveals glucose-dependent regulation of COL13A1 mRNA in Pompe patients: Prospect for a novel disease mechanism.Genes Dis2026https://conductscience.org/library/papers/41049133PubMed
40981304Umbilical Cord Blood Sampling for Newborn Screening of Pompe Disease and the Detection of a Novel Pathogenic Variant and Pseudodeficiency Variants in an Asian Population.Int J Neonatal Screen2025https://conductscience.org/library/papers/40981304PubMed
40947720Pompe Disease: A Review of Diagnosis, Molecular Genetics, and Treatment Management.Curr Cardiol Rev2026https://conductscience.org/library/papers/40947720PubMed
40801056Latest Advancements in Treatment Options for Infantile-Onset Pompe Disease: A Comprehensive Narrative Review.Clin Med Insights Pediatr2025https://conductscience.org/library/papers/40801056PubMed

See all 43 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD63967PubTator's text mininghttps://conductscience.org/library/genes/967NCBI Gene
CMPK151727PubTator's text mininghttps://conductscience.org/library/genes/51727NCBI Gene
GAA2548PubTator's text mininghttps://conductscience.org/library/genes/2548NCBI Gene
IFI3010437PubTator's text mininghttps://conductscience.org/library/genes/10437NCBI Gene
IGF2R3482PubTator's text mininghttps://conductscience.org/library/genes/3482NCBI Gene
ITGA73679PubTator's text mininghttps://conductscience.org/library/genes/3679NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36969713

GET https://conductscience.org/api/papers/v1/36969713/references?page=2